DERM vs PRU · rev $34.5M vs rev $31.19B
Journey Medical Corp (DERM) versus PRU (PRU) — a side-by-side from cached financials, not a winner call.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
PRU (PRU) common stock.
Latest reported DERM revenue for 2026-06-30 was $34.5M. Net income was -$2.5M. DERM currently screens at market cap $163.1M.
Latest reported PRU revenue for 2026-06-30 was $31.19B. Net income was $1.58B. PRU currently screens at market cap $0.
DERM currently screens at market cap $163.1M. PRU currently screens at market cap $0.
Not investment advice. Open the DERM and PRU stock pages for the full models.
Not investment advice.